{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:05:51Z","timestamp":1760267151713},"reference-count":27,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hong Kong Research Fund for the Control of Infectious Diseases","award":["10091432"],"award-info":[{"award-number":["10091432"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2012.02.009","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T18:17:15Z","timestamp":1329416235000},"page":"2605-2610","source":"Crossref","is-referenced-by-count":12,"title":["Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus"],"prefix":"10.1016","volume":"30","author":[{"given":"Ting","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kam-Leung","family":"Siu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kin-Hang","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Hung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric Y.T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan F.N.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin K.W.","family":"To","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.K.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Jian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Yung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.02.009_bib0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","article-title":"Guillain-Barr\u00e9 syndrome: an update","volume":"16","author":"Vucic","year":"2009","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0010","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain-Barr\u00e9 syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/594124","article-title":"Guillain-Barr\u00e9 syndrome and influenza virus infection","volume":"48","author":"Sivadon-Tardy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.amepre.2010.05.022","article-title":"Evaluation of Guillain-Barr\u00e9 syndrome among recipients of influenza vaccine in 2000 and 2001","volume":"39","author":"Burwen","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","article-title":"Guillain-Barr\u00e9 syndrome after exposure to influenza virus","volume":"10","author":"Lehmann","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2012.02.009_bib0030","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/cid\/ciq006","article-title":"Perspective: Swine-origin influenza: 1976 and 2009","volume":"52","author":"Sencer","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0040","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.aje.a113809","article-title":"An epidemiologic and clinical evaluation of Guillain-Barr\u00e9 syndrome reported in association with the administration of swine influenza vaccines","volume":"119","author":"Langmuir","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/603560","article-title":"Prepandemic immunization for novel influenza viruses, swine flu vaccine, Guillain-Barr\u00e9 syndrome, and the detection of rare severe adverse events","volume":"200","author":"Evans","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0050","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1016\/j.vaccine.2010.09.021","volume":"28","author":"Vellozzi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/aje\/kwr072","article-title":"Guillain-Barr\u00e9 syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A\/H1N1 viruses","volume":"174","author":"Grimaldi-Bensouda","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0060","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1006736","article-title":"Safety and effectiveness of a 2009 H1N1 vaccine in Beijing","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa1008553","article-title":"Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China","volume":"364","author":"Liang","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0070","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/j.vaccine.2011.01.056","article-title":"Adverse events following pandemic influenza vaccine Pandemrix\u00ae reported in the French military forces-2009\u20132010","volume":"29","author":"Mayet","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0075","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(11)61665-6","article-title":"Guillain-Barr\u00e9 syndrome and H1N1 influenza vaccine in UK children","volume":"378","author":"Verity","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0080","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1016\/j.vaccine.2011.08.069","article-title":"Guillain-Barr\u00e9 syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series","volume":"29","author":"Andrews","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/glycob\/cwp027","article-title":"Antiganglioside antibodies and their pathophysiological effects on Guillain-Barr\u00e9 syndrome and related disorders \u2013 a review","volume":"19","author":"Kaida","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/589624","article-title":"Anti-ganglioside antibody induction by swine (A\/NJ\/1976\/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barr\u00e9 syndrome","volume":"198","author":"Nachamkin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0095","doi-asserted-by":"crossref","first-page":"e16809","DOI":"10.1371\/journal.pone.0016809","article-title":"Antibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/653940","article-title":"Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009","volume":"51","author":"Hung","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0105","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1089\/fpd.2009.0493","article-title":"Association study between an outbreak of Guillain-Barr\u00e9 syndrome in Jilin, China, and preceding Campylobacter jejuni infection","volume":"7","author":"Zhang","year":"2010","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0110","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12028-010-9365-y","article-title":"Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection","volume":"13","author":"Kutle\u015da","year":"2010","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0120","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/j.1468-1331.2009.02569.x","article-title":"Sensori-motor Guillain-Barr\u00e9 syndrome with anti-GD1b antibodies following influenza A infection","volume":"16","author":"Simpson","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0125","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1471-4159.2010.07029.x","article-title":"Antibodies against ganglioside complexes in Guillain-Barr\u00e9 syndrome and related disorders","volume":"116","author":"Kusunoki","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0130","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.02.009_bib0135","article-title":"No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies","author":"Wang","year":"2011","journal-title":"Influenza Other Respir Virus"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12001740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12001740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T03:52:41Z","timestamp":1543204361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12001740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":27,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X12001740"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.02.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}